Epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA sequence.
The global market for epigenetic device market is expected to be driven by the advancement in technology. The key drivers of the market are the increasing cases prevalence of cancer, growing ageing population and increase in obese population.

In 2021, the global Epigenetic market size will be US$ 7494.9 million and it is expected to reach US$ 11500 million by the end of 2027, with a CAGR of 7.4% during 2021-2027.
This report focuses on the global Epigenetic status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Epigenetic development in North America, Europe, Japan, China, Southeast Asia, India, etc.

Global Epigenetic Scope and Market Size
Epigenetic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Epigenetic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Reagents
Kits
Instruments
Enzymes
Services

Segment by Application
Academic Research Institutes
Biotechnology Companies
Biopharmaceutical Companies
Diagnostic Companies

By Region
North America
Europe
Japan
China
Southeast Asia
India

By Company
Illumina
Qiagen
Abcam
Merck & Co
Sigma-Aldrich
New England Biolabs
Thermo Fisher Scientific
Diagenode
Active Motif
Roche Diagnostics
Eisai
Novartis